Live Breaking News & Updates on Nonsegmental

Stay updated with breaking news from Nonsegmental. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Iltefat Hamzavi, MD: Long-Term Implications of New Data on Upadacitinib for Nonsegmental Vitiligo

In this segment of his AAD interview, Hamzavi discussed more about his team’s findings on upadacitinib as well as their implications and future in terms of research. ....

United States , Iltefat Hamzavi , American Academy Of Dermatology , Henry Ford Health System Department , Global Vitiligo Foundation , Henry Ford Health System ,

Oral Povorcitinib for Extensive Nonsegmental Vitiligo Yields Positive Results in Phase 2b Trial

This new data from the phase 2b trial on povorcitinib could lead to developments in the dermatology space for vitiligo patients.
....

France General , Khaled Ezzedine , Kurt Brown , Povorcitinib Global Program Head At Incyte , European Academy Of Dermatology , European Academy , Total Vitiligo Area Scoring Index , Vitiligo Area Scoring Index , Vice President , Povorcitinib Global Program Head , Announces Positive , Week Data , Study Evaluating Povorcitinib , Extensive Nonsegmental , Povorcitinib Significantly Improves Total , Facial Vitiligo , Phase 2b ,